ETHK Labs Inc.

Research ETHK Labs Inc. (1931.HK) on Bullrun: market cap HKD 544.54M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

Valuation Snapshot

latest market cap is HKD 544.54M.

Five-year financial history

YearRevenueNet incomeFree cash flowGross marginDiluted EPSCashTotal debtEquity
FY2025CNY 2.82BCNY 34.93M-CNY 1.01B20.1%n/aCNY 548.68MCNY 1.93BCNY 2.95B
FY2024CNY 3.16BCNY 260.42MCNY 148.39M23.8%0.17CNY 1.86BCNY 755.97MCNY 3.71B
FY2023CNY 3.09BCNY 238.16MCNY 251.92M21.7%0.18CNY 1.22BCNY 344.32MCNY 3.34B
FY2022CNY 2.75BCNY 210.00MCNY 215.39M22.1%0.16CNY 1.02BCNY 349.92MCNY 3.15B
FY2021n/an/an/an/a0.13n/an/an/a

Valuation history

YearSnapshot dateMarket capP/EDividend yieldAnnual dividend/share
20262026-10-18HKD 544.54Mn/an/a0

Dividend history

Latest trailing dividend snapshot: annual dividend/share 0 HKD.

YearDividends/share
FY20240.12 CNY
FY20230.03 CNY
FY20220.08 CNY
FY20210.06 CNY

About ETHK Labs Inc.

ETHK Labs Inc., an investment holding company, distributes In vitro diagnostic (IVD) products in Mainland China and internationally. The company operates through three segments: Distribution Business, After-sales Services, and Self-branded Products Business. It offers IVD analysers, reagents, and other consumables for various IVD testing categories, including hematology and body fluid, immunoassay, clinical chemistry, immunology, microbiology, and point-of-care testing.

Related stock research

Other Healthcare stocks

Frequently asked questions

What is ETHK Labs Inc.'s market cap?

ETHK Labs Inc.'s market capitalization is HKD 544.54M.

What does ETHK Labs Inc. do?

ETHK Labs Inc., an investment holding company, distributes In vitro diagnostic (IVD) products in Mainland China and internationally. The company operates through three segments: Distribution Business, After-sales Services, and Self-branded Products Business. It offers IVD analysers, reagents, and other consumables for various IVD testing categories, including hematology and body fluid, immunoassay, clinical chemistry, immunology, microbiology, and point-of-care testing.